Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Lixte Biotechnology Holdings (LIXT) is now available.
In a significant corporate update, the Company has announced the appointment of Dr. Jan Schellens as the new Chief Medical Officer, effective from June 3, 2024. This move could signal strategic shifts and expertise enhancement, capturing the attention of investors tracking leadership changes in the stock market.
Find detailed analytics on LIXT stock on TipRanks’ Stock Analysis page.